You just read:

Orexigen® Therapeutics' Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity

News provided by

Orexigen Therapeutics, Inc.

Dec 07, 2010, 06:25 EST